NEW YORK--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE:BMY) will host a teleconference at 8:00 a.m. EDT on Monday, June 7, 2010, to review data presented at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago. Company executives will provide an overview of data presented at the meeting on the oncology portfolio and address inquiries from investors and analysts.
Investors and the general public are invited to listen to a live webcast of the call at: http://investor.bms.com or by dialing 913-312-0711, confirmation code: 1985004. A replay of the call will be available beginning at 11:00 a.m. EDT on June 7 through midnight EDT on June 21. The replay can be accessed at http://investor.bms.com or by dialing 402-280-9013, confirmation code: 1985004.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines that help patients prevail over serious diseases. For more information, please visit www.bms.com.
KEYWORDS: United States North America New York
INDUSTRY KEYWORDS: Health Biotechnology Oncology Pharmaceutical